R&D Systems™ Recombinant Human LILRA6/CD85b/ILT8 Protein

Catalog No.	Quantity
9088T4050	50 μg

Catalog No. 9088T4050 Supplier R&D Systems™ Supplier No. 9088T4050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human LILRA6/CD85b/ILT8 Protein is derived from HEK293. The Recombinant Human LILRA6/CD85b/ILT8 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q6PI73
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 79168
• Molecular Weight (g/mol): Observed M.W.: 62-69kDa, reducing conditions, Theoretical M.W.: 47kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived human LILRA6/CD85b protein Gly24-Asn447,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Common Name: ILT8/CD85b/LILRA6
• Gene Symbol: LILRA6
• Biological Activity: Measured by its binding ability in a functional ELISA. When Recombinant Human LILRA6/CD85b/ILT8 is coated onto a microplate at 2μg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 binds with a typical ED50 = 0.1-0.6μg/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: Human embryonic kidney cell, HEK293-derived Gly24-Asn447, with a C-terminal 6-His tag
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining